- Article
- Source: Campus Sanofi
- 4 Jun 2025
Multiple Myeloma: Elderly Patients
Multiple myeloma in older adults
|
Multiple myeloma is predominantly a disease of the elderly1 |
|
Median age at diagnosis 68 years2* |
Elderly/frail patients have fewer treatment options than younger patients3,4
*2014 EU data
Patients >65 years of age have worse survival rates than younger patients1
Characteristics commonly found in elderly patients make treatment di cult1,4-6
Common symptoms can all be attributed to other etiologies in elderly patients
Difficulty of diagnosis in elderly patients3
.png)
|
50% of patients need 3 GP visits before diagnosis |
|
Average delay in diagnosis: 6 MONTHS |
There is an unmet medical need in this di cult-to-treat patient population
-
National Cancer Institute. Available at: https://seer.cancer.gov/statfacts/html/mulmy.html;
-
Raab MS, et al. Br J Haematol 2016;175(1):66 76;
-
Willan J, et al. Clin Interv Aging 2016;11:423–35;
-
Palumbo A, et al. Blood 2015;125:2068–74;
-
Fried J, et al. J Gerontol A Biol Sci Med Sci 2004;59:255–63;
-
NCCN Guidelines: Multiple Myeloma Version 4.2022. Available at: https://www.nccn.org/professionals/physician_gls/pdf/myeloma.pdf;
-
Chim CS, et al. Leukemia 2018;32:252–62;
-
Egan JB, et al. Blood 2012;120:1060–6;
-
Hutchins LF, et al. N Engl J Med 1999;341:2061–7;
-
Baijal P & Periyakoil V. Cancer J 2014;20:358–66.
MAT-AE-2300647-V1-Nov-23